Regulatory Reform Council Puts Off Concluding Discussion on Use of Clinical Intervention Study Data for Drug Applications

Regulatory Reform Council Chairman Motoyuki Oka The government’s Regulatory Reform Council has pushed down its target by half a year to June 2014 for winding up its discussion on allowing the use of data derived from clinical intervention studies, mainly...read more